MedTrace Logo

A Clinical Evaluation of the Treatment of Spider Veins on the Ankles

NCT02754479 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2023-05-09

Study results available
· View outcomes & findings →

Summary

To evaluate the safety and effectiveness of the Excel V system for the treatment of lower extremity spider veins on the ankles.

Conditions

  • Spider Veins

Interventions

DEVICE

Nd:YAG laser

Treatment of lower extremity spider veins

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Kelly Stankiewicz, MD FAAD · DuPage Medical Group

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-10
Primary Completion
2016-12-22
Completion
2017-03-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02754479 on ClinicalTrials.gov